Macquarie Group’s Allogene Therapeutics ALLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$166K	Hold	146,779	–	–	﹤0.01%	1549
2025 Q1	$214K	Hold	146,779	–	–	﹤0.01%	1531
2024 Q4	$313K	Hold	146,779	–	–	﹤0.01%	1479
2024 Q3	$411K	Hold	146,779	–	–	﹤0.01%	1497
2024 Q2	$342K	Hold	146,779	–	–	﹤0.01%	1513
2024 Q1	$656K	Hold	146,779	–	–	﹤0.01%	1422
2023 Q4	$471K	Hold	146,779	–	–	﹤0.01%	1474
2023 Q3	$465K	Hold	146,779	–	–	﹤0.01%	1448
2023 Q2	$729K	Hold	146,779	–	–	﹤0.01%	1403
2023 Q1	$725K	Hold	146,779	–	–	﹤0.01%	1415
2022 Q4	$923K	Sell	146,779 -593	-0.4%	-$3.73K	﹤0.01%	1436
2022 Q3	$1.6M	Sell	147,372 -1,097	-0.7%	-$11.9K	﹤0.01%	1297
2022 Q2	$1.69M	Hold	148,469	–	–	﹤0.01%	1352
2022 Q1	$1.35K	Hold	148,469	–	–	﹤0.01%	1471
2021 Q4	$2.22M	Buy	148,469 +140	+0.1%	+$2.09K	﹤0.01%	1347
2021 Q3	$3.81M	Hold	148,329	–	–	﹤0.01%	1180
2021 Q2	$3.87M	Hold	148,329	–	–	﹤0.01%	1209
2021 Q1	$5.24M	Sell	148,329 -454	-0.3%	-$16K	0.01%	897
2020 Q4	$3.76M	Hold	148,783	–	–	0.01%	933
2020 Q3	$5.61M	Hold	148,783	–	–	0.01%	798
2020 Q2	$6.37M	Buy	148,783 +2,004	+1%	+$85.8K	0.01%	741
2020 Q1	$2.85M	Hold	146,779	–	–	0.01%	841
2019 Q4	$3.81M	Hold	146,779	–	–	0.01%	873
2019 Q3	$4M	Hold	146,779	–	–	0.01%	820
2019 Q2	$3.94M	Hold	146,779	–	–	0.01%	837
2019 Q1	$4.24M	Hold	146,779	–	–	0.01%	819
2018 Q4	$3.95M	Buy	+146,779	New	+$3.95M	0.01%	809